World's Best Scientists 2026 revealed!
Ivan Bièche

Ivan Bièche

D-Index & Metrics

Medicine

D-Index
108
Citations
40751
World Ranking
6030
National Ranking
174

Ivan Bièche publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ivan Bièche sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 760 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ivan Bièche D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ivan Bièche sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 108 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ivan Bièche is affiliated with the Institute Curie in France and conducts research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. A significant portion of their work focuses on Oncology, Molecular Biology, and Cancer Research, with additional interests in Pulmonary and Respiratory Medicine and Surgery.

Their main research topics include Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Advanced Breast Cancer Therapies, Genetic Factors in Colorectal Cancer, BRCA Gene Mutations in Cancer, Cancer Immunotherapy and Biomarkers, and PARP Inhibition in Cancer Therapy.

Bièche's frequent publication venues demonstrate a strong presence in Cancer Research, Annals of Oncology, bioRxiv (Cold Spring Harbor Laboratory), Journal of Clinical Oncology, and Scientific Reports.

Recent papers include the following:

  • Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group, 2020, Annals of Oncology
  • Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer, 2020, Annals of Oncology
  • Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial, 2022, The Lancet Oncology
  • Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group, 2024, Annals of Oncology
  • Genomics to select treatment for patients with metastatic breast cancer, 2022, Nature

Bièche collaborates frequently with a number of coauthors, including Sophie Vacher, Maud Kamal, Julien Masliah-Planchon, Christophe Le Tourneau, and Anne Vincent-Salomon. These collaborations have contributed to extensive research output within their fields of study.

Best Publications

  • Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

    Christophe Le Tourneau;Christophe Le Tourneau;Jean Pierre Delord;Anthony Gonçalves;Céline Gavoille

  • Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.

    F. Mosele;J. Remon;J. Mateo;C. B. Westphalen

  • Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL, an Antisense Noncoding RNA Whose Expression Coclusters with ARF

    Eric Pasmant;Ingrid Laurendeau;Delphine Héron;Michel Vidaud

  • The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

    Magali Olivier;Anita Langerød;Patrizia Carrieri;Jonas Bergh

  • ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS

    Eric Pasmant;Audrey Sabbagh;Michel Vidaud;Ivan Bièche

  • Expression Analysis of DNA Methyltransferases 1, 3A, and 3B in Sporadic Breast Carcinomas

    Igor Girault;Sengül Tozlu;Rosette Lidereau;Ivan Bièche

  • Genetic alterations in breast cancer.

    Ivan Bièche;Rosette Lidereau

  • Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues.

    Ivan Bièche;Cèline Narjoz;Tarik Asselah;Sophie Vacher

  • Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.

    Alain Latil;Ivan Bièche;Dominique Vidaud;Rosette Lidereau

  • SWI/SNF Chromatin Remodeling and Human Malignancies

    Julien Masliah-Planchon;Ivan Bièche;Jean-Marc Guinebretière;Franck Bourdeaut

  • A refined molecular taxonomy of breast cancer

    M Guedj;L Marisa;A de Reynies;B Orsetti

  • Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature.

    Ivan Bièche;Florence Lerebours;Sengül Tozlu;Marc Espie

  • Real-Time Reverse Transcription-PCR Assay for Future Management of ERBB2-based Clinical Applications

    Ivan Bièche;Peter Onody;Ingrid Laurendeau;Martine Olivi

  • Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay

    Ivan Bièche;Ingrid Laurendeau;Sengül Tozlu;Martine Olivi

  • Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network

    M. Beau-Faller;N. Prim;A.-M. Ruppert;I. Nanni-Metéllus

  • Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C

    Tarik Asselah;Ivan Bieche;Stéphanie Narguet;Audrey Sabbagh

  • SLIT2, a Human Homologue of the Drosophila Slit2 Gene, Has Tumor Suppressor Activity and Is Frequently Inactivated in Lung and Breast Cancers

    Ashraf Dallol;Nancy Fernandes Da Silva;Paolo Viacava;John D. Minna

  • Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer

    Ivan Bièche;Martine Olivi;Marie-Hélène Champème;Dominique Vidaud

  • Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach

    S Tozlu;I Girault;S Vacher;J Vendrell

  • Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma

    Valerie Paradis;Asmae Benzekri;Delphine Dargère;Ivan Bièche

Frequent Co-Authors

Rosette Lidereau
Rosette Lidereau Institute Curie
Michel Vidaud
Michel Vidaud Université Paris Cité
Eric Raymond
Eric Raymond St. Joseph Hospital
Valérie Paradis
Valérie Paradis Université Paris Cité
Anne Vincent-Salomon
Anne Vincent-Salomon Institute Curie
Jean-Yves Pierga
Jean-Yves Pierga Institute Curie
Patrick Marcellin
Patrick Marcellin Université Paris Cité
Dominique Valla
Dominique Valla Université Paris Cité
Diane Damotte
Diane Damotte Hôtel-Dieu de Paris

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens the door to many rewarding pathways beyond traditional MD programs. For those interested in patient care but seeking an alternative route, consider a nursing school that doesn't require teas exams. These schools offer accessible entry points for future nurses who wish to bypass certain standardized tests.

If you are drawn to the business side of healthcare, a healthcare administration online degree provides flexibility and the skills needed to excel in hospital management or healthcare policy roles.

Registered nurses aiming for advanced practice should look into adn to fnp bridge programs, which offer a direct pathway to becoming a Family Nurse Practitioner with higher earning potential and broader clinical opportunities.

Additionally, nutrition is a fast-growing healthcare field. Earning online degrees in nutrition can open doors to roles in wellness coaching, research, and clinical dietetics—many programs offer flexibility for busy adults.

Best Scientists Citing Ivan Bièche

Trending Scientists

Recently Published Articles